Developing new glutaminase inhibitors with potential anti-tumor activity
Multi-user Equipment approved in grant* 2021/05726-6: MuviCyte
Epigenetic study of histone demethylases enzymes Fe (II) and ±-ketoglutarate depen...
Evaluation of synergy between immune checkpoint blockade therapy with anti-PD-1 an...
Glutaminase 1 and the Remodeling of the Immune Microenvironment in Triple-Negative...
Study of alternative anaplerotic sources of the TCA as new targets against triple-...